Metabolic effects of sulforaphane oral treatment in streptozotocin-diabetic rats

scientific article published in September 2012

Metabolic effects of sulforaphane oral treatment in streptozotocin-diabetic rats is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/JMF.2012.0016
P698PubMed publication ID22925073
P5875ResearchGate publication ID230747036

P50authorDiogo O SouzaQ39272593
P2093author name stringAnderson Rech
Carolina Guerini de Souza
Marcos Luiz Santos Perry
Adriano Martimbianco de Assis
José Augusto Sattler
P433issue9
P304page(s)795-801
P577publication date2012-09-01
P1433published inJournal of Medicinal FoodQ15759825
P1476titleMetabolic effects of sulforaphane oral treatment in streptozotocin-diabetic rats
P478volume15

Reverse relations

cites work (P2860)
Q37125260Broccoli sprout extract prevents diabetic cardiomyopathy via Nrf2 activation in db/db T2DM mice
Q90207068Broccoli sprouts juice prevents lens protein aggregation in streptozotocin-induced diabetic rat
Q50881861Chronic sulforaphane oral treatment accentuates blood glucose impairment and may affect GLUT3 expression in the cerebral cortex and hypothalamus of rats fed with a highly palatable diet.
Q40120636Effect of a trans fatty acid-enriched diet on biochemical and inflammatory parameters in Wistar rats
Q88499143Extracellular Matrix Remodeling and Modulation of Inflammation and Oxidative Stress by Sulforaphane in Experimental Diabetic Peripheral Neuropathy
Q40521509LPS-induced expression of CD14 in the TRIF pathway is epigenetically regulated by sulforaphane in porcine pulmonary alveolar macrophages.
Q39390402Metabolic syndrome: pathophysiology, management, and modulation by natural compounds
Q38721709Protective role of sulphoraphane against vascular complications in diabetes
Q35859481Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficient mdx Mice via NF-E2-related Factor 2 (Nrf2)-mediated Inhibition of NF-κB Signaling Pathway
Q28393421Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation
Q53725001Sulforaphane ameliorates the insulin responsiveness and the lipid profile but does not alter the antioxidant response in diabetic rats.
Q33865037Sulforaphane reduces vascular inflammation in mice and prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway.
Q99408758Sulforaphane response on aluminum-induced oxidative stress, alterations in sperm characterization and testicular histomorphometry in Wistar rats
Q45387265The Sulforaphane and pyridoxamine supplementation normalize endothelial dysfunction associated with type 2 diabetes

Search more.